ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 187 filers reported holding ACORDA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.38 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $0 | – | 90 | -18.2% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 110 | -84.2% | 0.00% | -100.0% |
| Q1 2019 | $18,000 | -5.3% | 698 | -45.2% | 0.00% | -55.6% |
| Q4 2018 | $19,000 | -20.8% | 1,273 | +2.6% | 0.01% | -10.0% |
| Q3 2018 | $24,000 | -35.1% | 1,241 | -5.2% | 0.01% | -37.5% |
| Q2 2018 | $37,000 | +15.6% | 1,309 | -3.6% | 0.02% | +23.1% |
| Q1 2018 | $32,000 | +14.3% | 1,358 | +1.4% | 0.01% | +18.2% |
| Q4 2017 | $28,000 | -28.2% | 1,339 | -19.4% | 0.01% | -47.6% |
| Q3 2017 | $39,000 | +62.5% | 1,662 | +33.1% | 0.02% | +61.5% |
| Q2 2017 | $24,000 | +60.0% | 1,249 | +69.9% | 0.01% | +62.5% |
| Q1 2017 | $15,000 | +1400.0% | 735 | +1212.5% | 0.01% | +700.0% |
| Q3 2016 | $1,000 | 0.0% | 56 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $1,000 | -66.7% | 56 | -60.0% | 0.00% | -50.0% |
| Q1 2016 | $3,000 | -57.1% | 140 | -23.1% | 0.00% | -50.0% |
| Q4 2015 | $7,000 | – | 182 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 428,000 | $8,046,000 | 1.90% |
| SCOPIA CAPITAL MANAGEMENT LP | 4,532,067 | $85,203,000 | 1.61% |
| DLD Asset Management, LP | 247,300 | $4,656,000 | 1.52% |
| Broadfin Capital, LLC | 644,153 | $12,110,000 | 1.34% |
| Perceptive Advisors | 720,000 | $13,536,000 | 0.96% |
| DLD Asset Management, LP | 135,493 | $2,547,000 | 0.83% |
| Malaga Cove Capital, LLC | 51,013 | $971,000 | 0.64% |
| Baker Brothers Advisors | 3,301,791 | $62,074,000 | 0.61% |
| Worth Venture Partners, LLC | 29,300 | $551,000 | 0.59% |
| Spark Investment Management LLC | 327,900 | $6,164,000 | 0.51% |